investiment.io
Tevogen Bio Holdings Inc.
$1.38
0.34 (32.69%)
Tevogen Bio Holdings Inc.
$1.38
0.34 (32.69%)
TVGN Price Chart
| Basic | |
|---|---|
| Market Cap | $69.95M |
| Price | $1.56 |
| 52 Week Range | 0.4-21.09 |
| Beta | 0.35 |
| Margins | |
| Gross Profit Margin | 0.00% |
| Operating Profit Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Valuation (TTM) | |
| P/E Ratio | 51.81 |
| Price to Sales Ratio | 0.00 |
| Price to Book Ratio | -27.87 |
| PEG Ratio | 0.53 |
Industry
Biotechnology
Sector
Healthcare
Full-Time Employees
17
Website
IPO Date
2022-01-05T00:00:00.000Z
Description
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Phone
877 838 6436
Address
15 Independence Blvd, Warren, NJ, 07059, US
CIK
0001860871